Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization.

J Biol Chem

Bone Research Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

Published: August 1991

Biglycan (PG-I, DS-PG-1, PG-S1) is a small cellular or pericellular matrix proteoglycan that is closely related in structure to two other small proteoglycans, decorin (PG-II, PG-S2, DS-PG2, or PG-40) and fibromodulin. The core protein is made up predominantly of a series of 11 tandem repeats that appear to have been used throughout evolution for protein-protein, protein-cell, or cell-cell interactions. The function of biglycan is unclear at this time, but it has been shown to bind transforming growth factor beta in vitro. We have cloned and partially sequenced the approximately 8-kilobase pair human biglycan gene. The gene consists of eight exons including one in the sequence that encodes the 5'-untranslated region of the mRNA. The first and seventh introns are approximately 1 kilobase pair, while the remainder are shorter. With the exception of the first two introns, all of the introns are spread throughout the hydrophobic repeat domain. The 500-base pair 5' to the start of transcription contains several elements that strongly suggest that it contains a significant amount of the gene promoter. The elements include one AP2 and five SP1 consensus sequences. Like in many other genes, the biglycan gene promoter lacks both a CAAT and TATA box but is rich in GC content. Using 3H-labeled cDNA and in situ hybridization and autoradiography of human chromosomes, the human gene was localized to the end of the long arm of the X chromosome (Xq27-ter). The relationship of biglycan to a number of other proteins containing the leucine-rich repeats is discussed with respect to homologies of cysteine regions immediately adjacent to the repeat sequences.

Download full-text PDF

Source

Publication Analysis

Top Keywords

biglycan gene
12
human biglycan
8
gene promoter
8
gene
6
biglycan
5
human
4
gene putative
4
putative promoter
4
promoter intron-exon
4
intron-exon junctions
4

Similar Publications

Recent genomic studies have allowed the subdivision of intracranial ependymomas into molecularly distinct groups with highly specific clinical features and outcomes. The majority of supratentorial ependymomas (ST-EPN) harbor ZFTA-RELA fusions which were designated, in general, as an intermediate risk tumor variant. However, molecular prognosticators within ST-EPN ZFTA-RELA have not been determined yet.

View Article and Find Full Text PDF

Background: Considering the significant participation of the microenvironment in the local aggressiveness of odontogenic keratocysts, this study aims to evaluate the expression of ADAMTS-1 and its substrates, versican, aggrecan and brevican in this locally invasive odontogenic cyst.

Methods: Immunohistochemistry and polymerase chain reaction (PCR) were conducted on 30 cases of odontogenic keratocysts (OKCs) and 20 dental follicles (DFs).

Results: The immunohistochemical expression of these proteins was predominantly cytoplasmic and granular across all samples.

View Article and Find Full Text PDF
Article Synopsis
  • Retinal pathological angiogenesis (PA) is linked to diseases like age-related macular degeneration and diabetic retinopathy, and this study explores the role of the protein biglycan (BGN) in this process using a mouse model.
  • The researchers found that BGN levels increased in the retinas of mice with oxygen-induced retinopathy and that inhibiting BGN led to reduced PA, suggesting BGN plays a crucial role in promoting this condition.
  • Further analysis indicated that BGN's effect on PA may involve the upregulation of another protein, CXCL12, and blocking the interaction between CXCL12 and its receptor significantly decreased PA in mice, highlighting the importance of pericytes in
View Article and Find Full Text PDF

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis.

Alzheimers Dement

December 2024

Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, BioClinicum, Stockholm, Sweden.

Introduction: We aimed to identify unique proteomic signatures of Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and Parkinson's disease dementia (PDD).

Methods: We conducted a comparative proteomic analysis of 33 post mortem brains from AD, DLB, and PDD individuals without dementia focusing on prefrontal, cingulate, and parietal cortices, using weighted gene co-expression network analyses with differential enrichment analysis.

Results: Network modules revealed hub proteins common to all dementias.

View Article and Find Full Text PDF

Biglycan promotes tumour proliferation and invasion in human colon cancers.

J Int Med Res

November 2024

Department of Molecular Diagnostics, The Tenth Affiliated Hospital, Southern Medical University, Dongguan, Guangdong Province, China.

Objective: To investigate the role of biglycan (BGN) in colon cancer progression.

Methods: The association between BGN mRNA levels and the survival time of patients with colon cancer was analysed by referencing data from the Gene Expression Omnibus and The Cancer Genome Atlas (TCGA). Gene Set Enrichment Analysis (GSEA) was conducted to explore gene sets and pathways associated with BGN.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!